Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Brolucizumab

Signs of anterior uveitis and intraocular inflammation in association with vasculitis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Stepanov A, et al. Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic. European Journal of Ophthalmology 33 : 1097-1104, No. 2, Mar 2023. Available from: URL: https://journals.sagepub.com/home/EJO Stepanov A, et al. Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic. European Journal of Ophthalmology 33 : 1097-1104, No. 2, Mar 2023. Available from: URL: https://​journals.​sagepub.​com/​home/​EJO
Metadaten
Titel
Brolucizumab
Signs of anterior uveitis and intraocular inflammation in association with vasculitis: 2 case reports
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47155-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Rosuvastatin

Case report

Multiple drugs

Case report

Dupilumab

Case report

BBIBP-CorV